ES / EN
- July 11, 2025 -
No Result
View All Result
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
Home Cuba

Cuba: clinical trials of COVID-19 vaccine candidate begin

In the initial stage, the vaccine will be administered at the National Toxicology Center (CENATOX) to 20 volunteers between 19 and 59 years old and a week later to another 20 people between 60 and 80 years old, those responsible for administering the vaccine explained.

by
  • OnCuba Staff
    OnCuba Staff,
  • OnCuba editorial staff
August 25, 2020
in Cuba
0
Start of clinical trials with the Cuban Soberana 01 COVID-19 vaccine candidate. Photo: Ismael
Francisco/Cubadebate.

Start of clinical trials with the Cuban Soberana 01 COVID-19 vaccine candidate. Photo: Ismael Francisco/Cubadebate.

This Monday Cuba began in Havana the clinical trials in humans of its first vaccine project against the SARS-CoV-2 coronavirus, the first two phases of which will last until the beginning of November and will involve 676 volunteers.

The trials of the formula, developed by scientists from the state-run Finlay Vaccine Institute and called Soberana 01, were authorized after its registration on August 13 in the registry of the Center for State Control of Medicines, Equipment and Medical Devices (CEDMEC).

The Cuban vaccine successfully passed the animal experimentation stage between May and August and is the first vaccine candidate from a Latin American country approved for clinical trials, according to the director of the Finlay Institute, Vicente Vérez.

In the initial stage, the vaccine will be administered at the National Toxicology Center (CENATOX) to 20 volunteers between 19 and 59 years old and a week later to another 20 people between 60 and 80 years old, those responsible for administering the vaccine explained.

Dr. Carlos Alberto González, head of the CENATOX Clinical Trials Unit, explained to Cubadebate that, when chosen as the clinical trials unit, his institution is “responsible for ensuring good clinical practices, in such a way that the subject’s safety is well protected and that the data are reliable, traceable, reproducible so that this study is transparent and auditable by the competent authorities.”

Cuban Soberana 01 vaccine

Related Posts

Sandra Sotolongo, co-director of the “inSurGENTES” project, during an activity in the vegetable garden. Photo: Courtesy.

Insurgents, an open-air revolution

July 10, 2025
Private business on Infanta and 23rd Streets, in Vedado, Havana. Photo: AMD.

MSMEs barely growing and their slowdown hinders competition and economic dynamism

July 9, 2025
Entrance to San Juan Park, located east of Santiago.

San Juan Hill: heritage in the attic?

July 6, 2025
Headquarters of the Matanzas People’s Court, where the trial was held. Photo: Matanzas People’s Court/Facebook.

Prosecutor’s Office requests up to 9 years in prison for synthetic drug trafficking in Matanzas

June 30, 2025

The second phase will begin on September 11 with the vaccination of the remaining volunteers until reaching the planned 676. Participants in the trials will receive two doses of the vaccine 28 days apart and their response will be studied over two months.

The Finlay Institute has set January 11, 2021 for the completion date of the vaccine study, the results of which would be available on February 1 to be published on the 15th of the same month.

Vérez explained when presenting the research that the clinical trial will be “randomized, controlled, adaptive and multicenter” and has the objective of evaluating the “safety, reactogenicity and immunogenicity” in the two-dose scheme.

Although human trials are beginning now, on July 28, three of the researchers from the team that developed the vaccine candidate inoculated themselves with the formula.

Cuba: COVID-19 vaccine project already tested on three researchers

Compared to the other most advanced vaccine projects today, developed from adenoviral vectors or inactivated viruses, the Cuban formula is based on a recombinant protein, although at the moment no further data on its development has been officially released.

The island, which has to date 3,717 cases of coronavirus―545 active cases―and 91 deaths from COVID-19, has faced outbreaks of the disease in its western provinces in recent weeks. The most complex situation is in Havana, where the authorities have reactivated the restrictive measures that had been relaxed in early July.

Cuba has a renowned biotechnology and pharmaceutical industry that currently produces eight vaccines against diseases such as meningitis, lung cancer (therapeutic) and solid tumors, among others.

EFE/OnCuba

  • OnCuba Staff
    OnCuba Staff,
  • OnCuba editorial staff
Tags: coronavirus in CubaCOVID-19 vaccinecuban society
Previous Post

Cuban Soberana 01 vaccine

Next Post

Cuba: another death from COVID-19 and new contagions drop to 15

OnCuba Staff

OnCuba Staff

OnCuba Staff

OnCuba Staff

Next Post
Several people walk down a street in Havana after the passage of Tropical Storm Laura. Photo: Ernesto Mastrascusa/EFE.

Cuba: another death from COVID-19 and new contagions drop to 15

A man walks by a fallen tree after Tropical Storm Laura in Havana, on Tuesday, August 25, 2020. Photo: Ernesto Mastrascusa/EFE.

Cuba starts recovery phase after a less damaging cyclone than expected

Photo: Otmaro Rodríguez.

Cuba: 89% of pediatric COVID-19 patients already discharged

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

Most Read

  • Flags of Cuba and the United States, seen in perspective in Havana. Photo: Otmaro Rodríguez.

    Trump reinstates hard-line Cuba embargo as Havana condemns US measure as “criminal”

    29 shares
    Share 12 Tweet 7
  • Lester Lescay: “I left Cuba because I didn’t want to spend my youth there.”

    17 shares
    Share 7 Tweet 4
  • San Juan Hill: heritage in the attic?

    12 shares
    Share 5 Tweet 3
  • Los Palacios, land of Cuban rice harvested by Vietnamese

    12 shares
    Share 5 Tweet 3
  • A sanctuary for jazz in Cuba: César López’s dream

    15 shares
    Share 6 Tweet 4

Most Commented

  • Photo: Kaloian.

    Private sector and tourism in Cuba. Why not?

    12 shares
    Share 5 Tweet 3
  • About us
  • Work with OnCuba
  • Terms of use
  • Privacy Policy
  • Moderation policy for comments
  • Contact us
  • Advertisement offers

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

No Result
View All Result
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}